Stockreport

PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF – Strong Sephience™ (sepiapterin) launch continues with unaudited Q4 global revenue of $92.5M –– Unaudited 2025 total product and royalty revenue of approximately $823M, [Read more]